AUD2.90
2.47% today
Australia, Dec 30, 06:10 am CET
ISIN
AU000000MSB8
Symbol
MSB
Sector
Industry

Mesoblast Target price 2024 - Analyst rating & recommendation

Mesoblast Classifications & Recommendation:

Buy
67%
Hold
33%

Mesoblast Price Target

Target Price AUD3.18
Price AUD2.90
Potential
Number of Estimates 3
3 Analysts have issued a price target Mesoblast 2025 . The average Mesoblast target price is AUD3.18. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 3 analysts: 2 Analysts recommend Mesoblast to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Mesoblast stock has an average upside potential 2025 of . Most analysts recommend the Mesoblast stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Revenue Million AUD 9.01 18.59
19.19% 106.29%
EBITDA Margin -917.43% -595.79%
0.17% 35.06%
Net Margin -1,773.29% -768.62%
8.28% 56.66%

3 Analysts have issued a sales forecast Mesoblast 2025 . The average Mesoblast sales estimate is

AUD18.6m
Unlock
. This is
106.29% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
AUD30.1m 233.66%
Unlock
, the lowest is
AUD9.6m 6.87%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 AUD9.0m 19.19%
2025
AUD18.6m 106.29%
Unlock
2026
AUD87.4m 370.44%
Unlock
2027
AUD355m 305.93%
Unlock
2028
AUD448m 26.35%
Unlock
2029
AUD1.2b 164.25%
Unlock

1 Analyst has issued an EBITDA forecast Mesoblast 2025 . The average Mesoblast EBITDA estimate is

AUD-111m
Unlock
. This is
34.02% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
AUD-111m 34.02%
Unlock
, the lowest is
AUD-111m 34.02%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 AUD-82.7m 19.06%
2025
AUD-111m 33.97%
Unlock
2026
AUD-11.2m 89.86%
Unlock
2027
AUD350m 3,214.29%
Unlock

EBITDA Margin

2024 -917.43% 0.17%
2025
-595.79% 35.06%
Unlock
2026
-12.85% 97.84%
Unlock
2027
98.57% 867.08%
Unlock

2 Mesoblast Analysts have issued a net profit forecast 2025. The average Mesoblast net profit estimate is

AUD-143m
Unlock
. This is
10.59% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
AUD-103m 35.80%
Unlock
, the lowest is
AUD-183m 14.64%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 AUD-160m 12.50%
2025
AUD-143m 10.59%
Unlock
2026
AUD-28.4m 80.13%
Unlock
2027
AUD98.9m 448.40%
Unlock
2028
AUD88.3m 10.75%
Unlock
2029
AUD429m 385.43%
Unlock

Net Margin

2024 -1,773.29% 8.28%
2025
-768.62% 56.66%
Unlock
2026
-32.47% 95.78%
Unlock
2027
27.87% 185.83%
Unlock
2028
19.69% 29.35%
Unlock
2029
36.16% 83.65%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Earnings Per Share AUD -0.14 -0.13
12.50% 7.14%
P/E negative
EV/Sales 179.04

2 Analysts have issued a Mesoblast forecast for earnings per share. The average Mesoblast <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

AUD-0.13
Unlock
. This is
7.14% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
AUD-0.09 35.71%
Unlock
, the lowest is
AUD-0.16 14.29%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 AUD-0.14 12.50%
2025
AUD-0.13 7.14%
Unlock
2026
AUD-0.02 84.62%
Unlock
2027
AUD0.09 550.00%
Unlock
2028
AUD0.08 11.11%
Unlock
2029
AUD0.38 375.00%
Unlock

P/E ratio

Current -20.81 1,001.06%
2025
-22.61 8.65%
Unlock
2026
-113.76 403.14%
Unlock
2027
32.65 128.70%
Unlock
2028
36.58 12.04%
Unlock
2029
7.54 79.39%
Unlock

Based on analysts' sales estimates for 2025, the Mesoblast stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

179.04
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
174.53
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 369.34 1,056.36%
2025
179.04 51.52%
Unlock
2026
38.06 78.74%
Unlock
2027
9.38 75.36%
Unlock
2028
7.42 20.86%
Unlock
2029
2.81 62.16%
Unlock

P/S ratio

Current 360.04 1,283.25%
2025
174.53 51.53%
Unlock
2026
37.10 78.74%
Unlock
2027
9.14 75.36%
Unlock
2028
7.23 20.86%
Unlock
2029
2.74 62.16%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today